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Biofilms are associated with a wide variety of bacterial infections and pose a serious problem in clinical medicine due to their
inherent resilience to antibiotic treatment. Within biofilms, persister cells comprise a small bacterial subpopulation that exhib-
its multidrug tolerance to antibiotics without undergoing genetic change. The low frequency of persister cell formationmakes it
difficult to isolate and study persisters, and bacterial persistence is often attributed to a quiescent metabolic state induced by
toxins that are regulated through toxin-antitoxin systems. Here wemimic toxins via chemical pretreatments to induce high lev-
els of persistence (10 to 100%) from an initial population of 0.01%. Pretreatment of Escherichia coliwith (i) rifampin, which
halts transcription, (ii) tetracycline, which halts translation, and (iii) carbonyl cyanidem-chlorophenylhydrazone, which halts
ATP synthesis, all increased persistence dramatically. Using these compounds, we demonstrate that bacterial persistence results
from halted protein synthesis and from environmental cues.
Within every bacterial population there is a small subpopula-tion that survives when challenged with a lethal antibiotic
treatment (1). This subpopulation of cells, known as persisters,
exhibits a nonhereditary (1),multidrug tolerance (2). Regrowth of
these persisters, by inoculation into fresh media, produces a pop-
ulation both genetically identical to the original culture and
equally susceptible to antibiotic treatment (2). Persisters are
found in all phases of cell growth, with a frequency of 0.0001 to
0.001% of the population in exponential-phase cultures and as
high as 1% in bacterial biofilms and stationary-phase cultures (3,
4). Biofilms consist of an extracellular polymericmatrix, which, in
some cases, acts as a physical barrier to protect bacteria from an-
timicrobials and/or host defense mechanisms and also contains
cells with a wide range of metabolic activities (5). Biofilms are
associated with numerous infections (6), including recalcitrant
infections of cystic fibrosis and gingivitis or infections on indwell-
ing devices (3, 7). Persister cells are the key to biofilm resilience
because survival of just a few persisters allows the biofilm to re-
populate (8). Persisters also cause recurrence of tuberculosis in-
fections (7), which are particularly difficult to treat in the lungs.
Therefore, persister cell research is necessary in order to devise
more effective medical treatments to combat infectious diseases.
Treatment of bacterial infections is complicated by both bac-
terial persistence and resistance, two distinct phenomena occur-
ring through unrelated mechanisms (3). Resistance is caused by
genetic variations, which result in the alteration of antibiotic tar-
gets to reduce antibiotic binding and efficacy (3). As a result, re-
sistant bacteria are able to survive and even grow in the presence of
antibiotics. Persistence is believed to arise from stochastic, physi-
ological differences (9) that induce a state of dormancy or low
metabolic activity (3). This is supported by the naturally higher
frequency of persister cells in the stationary phase as opposed to
the exponential phase. It is thought that persisters neither grow
nor die in the presence of antibiotics because antibiotics are un-
able to corrupt cellular processes in a cell with globally reduced
metabolism (3).
Toxin-antitoxin (TA) systems are prevalent in the bacterial
genome (at least 37 in Escherichia coli) (10) and are perceived as a
redundant, genetic basis for the formation of persisters from nor-
mal cells (11, 12). TA systems typically consist of two genes encod-
ing a stable toxin, which disrupts an essential cellular process, and
an unstable antitoxin, which mediates the effect of the toxin (7).
MqsR/MqsA is one such well-characterized TA system (13–19)
that is important to persistence (20–22). MqsR, the toxin, is an
RNase (18) which cleaves nearly all mRNA (23), and overproduc-
tion of MqsR was shown to significantly increase persistence (20–
22); deletion ofmqsR resulted in decreased persistence, which was
the first time the absence of a toxinwas shown to affect persistence
(21). TisB/IstR-1 is another TA system in which the toxin TisB
decreases ATP levels and induction of tisB transcription through
the SOS response increases persistence (24).
Persister cells are typically described as dormant, nondividing
cells with globally reduced metabolism (12, 20, 25); however, it is
not clear what exactly a persister cell is or what the extent of dor-
mancy is (26). A significant step in understanding the persistence
phenotype was the demonstration that cells exhibiting low levels
of translation are more likely to be persisters (20). An unstable
green fluorescent protein variant was inserted into the chromo-
some under the control of the ribosomal rrnBP1 promoter, which
is highly expressed under conditions of rapid growth (20). Cells
from an exponential-phase culture were individually sorted based
on the level of fluorescence to isolate the “dimmer” cells with low
levels of translation (20). These dimmer cells were 20-fold en-
riched in persisters, suggesting a correlation between persisters
and reduced protein synthesis (20).
Induction of the SOS response by a low-concentration fluoro-
quinolone pretreatment increased the persister population that
tolerated lethal antibiotic exposure (27). This suggests that in-
duced persistence is a side effect of antibiotic treatment and can be
triggered as a response to the environment. Based on the signifi-
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cant increase in persistence observed with overproduction of the
toxin MqsR (20–22) and with ciprofloxacin as an environmental
trigger for the SOS response (27), we hypothesized that perhaps
compounds which reduce protein synthesis could be used to
mimic the effects of toxins, like MqsR and TisB, to produce per-
sister cells. Hence, in this study, we disrupted protein synthesis via
rifampin (28) and tetracycline (29) and disrupted energy produc-
tion via carbonyl cyanide m-chlorophenylhydrazone (CCCP)
(30). Corroborating our hypothesis, use of these compounds to
inhibit transcription, inhibit translation, and inhibit ATP synthe-
sis induced persistence in a large percentage of the population (10
to 100%) in comparison to a maximum of1% observed in sta-
tionary-phase cultures (3). Based on our results, we conclude that
the level of bacterial persistence is proportional to the level of
halted protein synthesis and, additionally, have designed a novel
method for inducing a high level of persistence within any bacte-
rial population by utilizing a chemical pretreatment. The ability to
work with a culture consisting of almost entirely persister cells is a
useful tool for future persister research.
MATERIALS AND METHODS
Bacterial strains and growth conditions. Bacterial strains used are listed
in Table 1. All experiments were conducted at 37°C in Luria-Bertani (LB)
medium (31), with shaking at 250 rpm (liquid cultures).
MIC assay. The MIC of E. coli K-12 BW25113 to rifampin, tetracy-
cline, ampicillin, and ciprofloxacin was determined by incubating freshly
inoculated cultures in LB broth for 16 h with various concentrations of
each antibiotic and observing inhibition of growth based on lack of tur-
bidity. Experiments were performed with at least three independent cul-
tures.
Persister cell viability assay. The number of persister cells was deter-
mined based on an assessment of cell viability after antibiotic treatment by
serially diluting cultures in 0.85% NaCl solution, plating 10 l drops on
LB agar, and counting colonies (32). Both ciprofloxacin (5 g/ml) (33)
and ampicillin (100 g/ml) (34) treatments were used for 3 h, except for
the prolonged treatment with ciprofloxacin where 8 h was used. Concen-
trations were chosen to be at least 10 the MIC (ciprofloxacin, 0.01 to
0.05 g/ml; ampicillin, 5 to 10 g/ml) to minimize survival of potential
spontaneous resistant mutants, and treatments lasted 3 h to ensure erad-
ication of nonpersisters. Cultures of E. coli K-12 BW25113 were diluted
1:1,000 in fresh LB broth from a 16-h overnight inoculum and grown to
mid-exponential phase (turbidity of 0.8 at 600 nm) before either adding
antibiotics (ciprofloxacin or ampicillin) and quantifying the number of
persisters or pretreating with compounds that reduce protein synthesis
and then adding antibiotics (ciprofloxacin or ampicillin) and quantifying
the number of persisters. Pretreated cultures were exposed to rifampin
(100 g/ml for 30 min), tetracycline (50 g/ml for 30 min), or CCCP (50
g/ml for 3 h). Cultures were centrifuged and resuspended in fresh LB
broth to remove the pretreatment compounds prior to quantifying per-
sister cells after exposure to ciprofloxacin or ampicillin. The pretreatment
concentrations and durations were optimized to produce the highest sur-
vivability for this study. Concentrations of rifampin (100 g/ml) and
tetracycline (50 g/ml) were both significantly higher than the MICs, 10
to 20g/ml and 0.5 to 1g/ml, respectively. Experiments were performed
with at least four independent cultures.
Persister revival assay. The time required for the revival of induced
persister cells was determined based on growth curves for cultures after
pretreatment. Cultures of E. coli K-12 BW25113 were diluted 1:1,000 in
fresh LB broth from a 16-h overnight inoculum and grown to mid-expo-
nential phase (turbidity of 0.8 at 600 nm) before being pretreated with
rifampin (100 g/ml for 30 min), tetracycline (50 g/ml for 30 min), or
CCCP (50 g/ml for 3 h). Following pretreatment, cultures were centri-
fuged and resuspended in fresh LB broth to remove the pretreatment
compounds and then diluted to a turbidity of 0.1 at 600 nm. Experiments
were performed with at least four independent cultures.
Merodiploid construction.Themerodiploid strainswere constructed
by conjugation between a multiply auxotrophic donor carrying F=110 or
F=110-1 and selecting forMet prototrophy withMB411. Rifampin resis-
tance was scored for confirmation. Persistence was tested as above, except
with 25 g/ml rifampin pretreatment, a concentration allowing normal
growth of the resistant merodiploid, with at least three independent cul-
tures.
RESULTS
For this study, ciprofloxacin and ampicillin were the bactericidal
antibiotics chosen for treatments to isolate persister cells. Cipro-
floxacin, a fluoroquinolone, binds to DNA and affects the activity
of DNA gyrase, inhibiting DNA replication (33). Ciprofloxacin is
effective at killing cells in all phases of growth (33), making it an
appropriate antibiotic to isolate persister cells regardless of
whether pretreatment affects replication. Ampicillin, a -lactam,
binds to transpeptidase and carboxypeptidase, inhibiting cell wall
synthesis (34). The disruption of these enzymes leads to lethal
defects of the cell wall and also cell lysis during the process of cell
replication (34). It should be noted that ampicillin has reduced
efficacy in treating nongrowing or slow-growing cells (35). Ampi-
cillin was used in this study, in addition to ciprofloxacin, to isolate
persister cells and test for multidrug tolerance of pretreated cul-
tures, indicative of bacterial persistence.
Rifampin pretreatment increases persistence. Rifampin is a
bacteriostatic antibiotic (36) which inhibits mRNA synthesis (37)
by binding and inactivating RNA polymerase (28), thereby pre-
venting transcription. We reasoned that rifampin pretreatment
could be used to increase persistence by inhibiting transcription,
consistent with overproduction of MqsR, which cleaves nearly all
mRNA. Hence, we tested whether a pretreatment of E. coli with
rifampin would increase persistence. To pretreat the cells, we ex-
posed cells to rifampin (100 g/ml) during the mid-exponential
phase for 30 min. Rifampin pretreatment conditions were opti-
mized for maximum survivability, and altering the concentration
and duration led to varied survivability. Our results showed that
cultures pretreatedwith rifampin displayed significantly increased
persistence (1,000- to 10,000-fold increase over untreated cul-
tures), with 59% of the pretreated population surviving cipro-
floxacin treatment and 69% surviving ampicillin treatment
(Fig. 1).
To verify our results, we observed that pretreatment only
caused a modest amount of cell death, with 57% of the initial
population surviving rifampin exposure, confirming that persis-
tence is not artificially increased by eradication of nonpersisters
via pretreatment. We also tested whether the formation of spon-
TABLE 1 Bacteria used in this study
E. coli K-12
strain Description
Source or
reference
BW25113 lacIq rrnBT14 lacZWJ16 hsdR514 araBADAH33
rhaBADLD78
48
MB411 hsdR514 glnV44 tryT58 lacY1 galK2 galT22
metB1 trpR55
This study
MB4814 MB411 F=110metB rpoB This study
MB4815 MB411 F=110metB rpoB This study
MB4816 MB411 F=110–1metB rpoB3 (Rifr) This study
MB4817 MB411 F=110–1metB rpoB3 (Rifr) This study
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taneous resistant mutants affected our results by checking for
growth of the persister cultures plated on LB agar plates contain-
ing ampicillin or ciprofloxacin, respective of prior treatment. Our
results showed that spontaneous resistant mutants contribute to
less than 0.0001% of the induced persister population, with no
observable growth up to the limit of detection. An important con-
sideration, regarding the choice of antibiotics, is that pretreatment
may lead to a state of diminished growth, similar to stationary
phase, which would reduce the efficacy of ampicillin. However,
increased survival to ciprofloxacin after rifampin treatment con-
firms the persistence phenotype because ciprofloxacin eradicates
cells with reduced growth. Therefore, we achieved a consistent
increase in persistence to antibiotics of two separate classes.
Rifampin-induced persisters show a characteristic lag in re-
vival and slow loss of viability. To provide further evidence that
the rifampin pretreatment induced persistence, we performed a
revival assay of cultures pretreated with rifampin since persister
cells exhibit a lag before resumption of normal growth (25). As
expected for persister cells, we found that rifampin-pretreated
cultures displayed a lag of4 h (Fig. 2). The delay before growth
following exposure to rifampin has previously been described as a
“post-antibiotic effect,” caused by the lack of mRNA (38). The lag
before resumption of normal growth, reduced levels of mRNA,
and increased survival to antibiotics are all characteristics that are
associated with both persister cells and rifampin-treated cells.
These correlations suggest that the “post-antibiotic effect” of ri-
fampin is physiologically the same as that in persister cells, so we
conclude that rifampin pretreatment induces a persister-like state.
Since antibiotic treatment of bacterial cultures produces bi-
phasic cell death, with persister cells surviving extended peri-
ods of time, exhibiting slow, steady cell death (39), we tested
the rifampin-pretreated cells to see if they demonstrated this
slow loss of viability that is characteristic of persister cells.
Hence, we exposed pretreated cultures to ciprofloxacin for a
prolonged period, quantifying the number of viable cells at
several time points. Our results reflect slow, steady cell death
for up to 8 h of antibiotic treatment (Fig. 3), which is charac-
FIG 1 Persistence induced with rifampin, tetracycline, and CCCP pretreat-
ments. Cell survival (%) after treatment with ciprofloxacin (5 g/ml) (a) and
ampicillin (100 g/ml) (b) for 3 h. Exponential-phase cultures of the E. coli
K-12 BW25113 wild type were pretreated with rifampin (100 g/ml for 30
min), tetracycline (50 g/ml for 30 min), and CCCP (50 g/ml for 3 h) prior
to antibiotic exposure. Data from four independent cultures are shown along
with one standard deviation.
FIG 2 Revival of rifampin-, tetracycline-, and CCCP-induced persisters. Re-
sumption of growth (monitored with turbidity) for persisters subsequent to
pretreatments. Exponential-phase cultures of the E. coli K-12 BW25113 wild
type were pretreated with rifampin (100 g/ml for 30 min), tetracycline (50
g/ml for 30 min), and CCCP (50 g/ml for 3 h) prior to growth in fresh LB
media. Representative data from two independent cultures are shown along
with one standard deviation.
FIG 3 Prolonged antibiotic exposure of rifampin-induced persisters. Cell sur-
vival (%) during prolonged treatment with ciprofloxacin (5g/ml). Exponen-
tial-phase cultures of the E. coliK-12 BW25113 wild type were pretreated with
rifampin (100 g/ml for 30 min) prior to antibiotic exposure. Data from four
independent cultures are shown along with one standard deviation.
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teristic of persister cell cultures. Therefore, our rifampin-in-
duced persisters are “true” persisters.
Rifampin induces persistence by arresting transcription.
Our hypothesis is that rifampin increases persistence by halting
protein synthesis via inhibition of transcription. This suggests that
rifampin-resistant mutants would no longer show a rifampin-in-
duced increase in persistence. Three independent spontaneous
rifampin-resistant mutants behaved consistently with this predic-
tion. These strains showed no effect of rifampin pretreatment,
producing less than a 4-fold difference in antibiotic persistence
with and without pretreatment in comparison to a 13,000-fold
increase in persistence for the pretreatedwild-type culture. Rifam-
pin-resistant mutants yielded between 0.0001 to 0.002% persis-
tence, identical to themagnitude of survival for the wild-type par-
ent without pretreatment.
Another important consideration was to check whether the
induced persistence is actually the result of arrested transcription,
rather than a cellular response from the inhibition of RNA poly-
merase. Merodiploid strains (two independent strains) contain-
ing both wild-type and rifampin-resistant (rpoB/rpoB3) alleles
were compared to the wild type (rpoB/rpoB) for persister for-
mation upon rifampin pretreatment. If rifampin induces persis-
tence through inhibition of transcription, then carrying a rifam-
pin-resistant allele will allow continued transcription and should
reduce the effect of pretreatment.Without pretreatment, both the
rpoB/rpoB3 and rpoB/rpoB merodiploids showed the same
magnitude of antibiotic persistence (0.2 to 2%). However, rifam-
pin pretreatment increased persistence100-fold for the rpoB/
rpoB strains, with a reduced effect of 10-fold for the rpoB/
rpoB3 strains. Therefore, the presence of a rifampin-resistant allele
in the merodiploids reduced persistence10-fold, allowing us to
conclude that rifampin pretreatment induces persistence by inhi-
bition of transcription and not via a cellular signal from the wild-
type polymerase.
Tetracycline induces persistence similarly to rifampin.Based
on our findings that rifampin induces persistence through inhib-
ited transcription, we decided to test whether inhibiting transla-
tion would also induce persistence. We found that pretreatment
with tetracycline, a translation inhibitor (29), significantly in-
creased persistence. Cultures were pretreated with tetracycline in
the samemanner aswith rifampin (conditions optimized formax-
imum survivability), resulting in 47% survival to ciprofloxacin (5
g/ml) and 21% survival to ampicillin (100 g/ml) (Fig. 1). A
majority of cells (60%) survived the tetracycline exposure, con-
firming that persistence was not artificially increased and that a
reduction in protein synthesis increases persistence.
We also performed a revival assay and found that tetracycline-
pretreated cultures displayed a lag in revival of2 h (Fig. 2). The
“post-antibiotic effects” of tetracycline (40), a combination of the
lag before growth, reduced protein levels (from inhibition of pro-
tein synthesis), and increased survival to antibiotics, are consistent
with rifampin pretreatment, so we conclude that tetracycline pre-
treatment also produces persister cells. The corroboration of re-
sults from rifampin and tetracycline pretreatments suggests that
inhibiting protein synthesis is the key to making persister cells.
Preliminary tests with streptomycin (100 g/ml) and trim-
ethoprim (10 g/ml) had a similar effect, both displaying 1%
survival to ampicillin (100 g/ml), but pretreatments with these
compounds were not optimized.
CCCP induces persistence. After our success at inducing per-
sistence through mechanisms acting similarly to the toxin MqsR,
we hypothesized thatmimicking the toxin TisB would also induce
persistence. Since the toxin TisB decreases cellular ATP (24), we
tested pretreatment with the metabolic poison CCCP, an uncou-
pling agent that inhibits ATP synthesis (30). Using a pretreatment
of CCCP to reduce cellular ATP (optimized for maximum surviv-
ability), we observed 76% persistence to ciprofloxacin and 64%
persistence to ampicillin, similar to the results with rifampin and
tetracycline (Fig. 1). As with the other pretreatments, 47% of cells
survived CCCP exposure, confirming that persistence was not ar-
tificially increased and a reduction in metabolism increases per-
sistence.
CCCP-induced persisters show characteristic lag in revival.
As with the rifampin and tetracycline pretreatments, we per-
formed a revival assay following CCCP pretreatment to character-
ize the induced survivability as persistence. Our results showed a
lag in revival of0.5 to 1 h (Fig. 2) following CCCP pretreatment,
which is shorter than that induced by antibiotics. We reason that
the recovery time is reduced because CCCP diminishes metabolic
activity without directly inhibiting mRNA or protein synthesis.
Therefore, we conclude that CCCP pretreatment does in fact in-
duce persistence.
DISCUSSION
Persister cells have frequently been characterized as dormant cells
in a state of low metabolism (12, 20, 25), although few experi-
ments have been performed to verify this. Several TA systems have
been suggested as the basis of persister cell formation (12, 21, 22).
In this study, we have shown that bacterial persistence can be
induced with pretreatments that affect transcription and transla-
tion. We first attempted to mimic the effects of the toxin MqsR
(18) and found that temporary exposure of cells to rifampin, to
inhibit transcription, significantly increased subsequent survival
to treatment with the bactericidal antibiotics ciprofloxacin and
ampicillin (Fig. 1), two different classes of bactericidal antibiotics.
This shows that the rifampin-induced survivor cells exhibit mul-
tidrug tolerance, which is indicative of bacterial persistence (2).
The order of magnitude of these persister cells was consistently
between 10 to 100%, a considerably higher level than the0.01%
persistence we found in exponentially growing cells (Fig. 1) and
the1% persistence observed in stationary-phase cultures (3, 4).
This high increase in percentage of persister cells can have several
applications, considering the low frequency of naturally forming
persisters.
Similarly to our rifampin pretreatment, we found that tetracy-
cline, which binds the ribosome to inhibit translation, also pro-
duced a high level of persistence (Fig. 1). Since both rifampin and
tetracycline effectively prevent translation, the corroboration of
these results shows that lack of protein synthesis is a key to bacte-
rial persistence. Our conclusion is consistent with previous re-
search that indicates a correlation between persister cells and re-
duced protein synthesis (20). It was shown that cells exhibiting
low levels of translation were 20-fold more persistent than a nor-
mal culture (20). With our pretreatments, we have induced per-
sistence in nearly 100% of the cell population by blocking protein
synthesis (1,000- to 10,000-fold increased persistence). Our re-
sults suggest that persisters are cells exhibiting essentially a com-
plete lack of protein synthesis.
Pretreating cells with rifampin or tetracycline to induce persis-
tence was effective at imitating the effect of overexpressing the
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toxin MqsR. However, it is important to note that rifampin and
tetracycline block all protein synthesis, whileMqsR allows contin-
ued translation of 14 mRNA lacking GCU cleavage sites (23) and
transcripts whose GCU sites are blocked by mRNA secondary
structure or protein binding. Therefore, it seems that naturally
formed persisters arrest protein synthesis, except for the contin-
ued synthesis of a few select proteins. These specific proteins may
have an important role in maintaining the viability of the persist-
ers, or may be coincidental, so further study is warranted.
After success with mimicking the effect of MqsR, we also tried
to mimic another toxin linked to persister cell formation, TisB
(24). We did this by testing whether the uncoupling agent CCCP
had a similar effect on persistence when used as a pretreatment.
We found that this metabolic poison induced persistence along
the same order of magnitude as that observed for pretreatments
with rifampin and tetracycline (Fig. 1). Based on our supposition
that bacterial persistence is the general lack of protein synthesis,
we postulate that the inhibition of ATP synthesis fromCCCP (30)
forces the cells to halt metabolic activity and become persister
cells. We conclude that any TA system capable of inhibiting pro-
tein synthesis, either directly (e.g., inhibition of transcription) or
indirectly (e.g., inhibition of ATP synthesis), provides ameans for
persister cell formation.
Combination therapy withmultiple antibiotics is often used to
treat infections as an added measure to prevent development of
bacterial resistance and to achieve antibiotic synergism (41). Ri-
fampin (42) and tetracycline (43) have often been used in combi-
nation therapy against infections from a wide range of microor-
ganisms. The results of this study suggest that the use of these two
compoundsmay induce persistence and lead to a reduced or failed
treatment from additional antibiotics.
Our newfound ability to produce a culture consisting almost
entirely of persister cells allows utilization of techniques designed
to study population-wide characteristics. Previously, the low fre-
quency of persister cells hasmade it difficult to isolate enough cells
for transcriptome and proteome experiments. Using chemical
pretreatments to produce high-persister cultures will be useful in
studying additional aspects of persistence; for example, we can
better study gene expression of persister cells to determine the
extent of dormancy required for persistence. Abundant persisters
also allow us to more easily study how persister cells revive and
determine methods for altering revival. Gaining a better under-
standing of the extent of dormancy required for persistence and
uncovering the dynamics of revival will allow research to progress
in designing methods to eliminate persisters.
As with all biological studies, laboratory conditions need to be
evaluated with regard to naturally occurring conditions. In this
study, chemical pretreatment may introduce unwanted physio-
logical responses that are not relevant to the natural persister phe-
notype; the pretreatment compoundsmimic the activity of toxins,
so the high levels of persistence arise as a direct consequence of the
chemical pretreatments. Caution is also advised for studying the
revival of these chemically induced persisters because it is not
known whether resumption of growth is distinct from that of
natural persistence (i.e., regulated by TA systems). Therefore, this
induced state of dormancy should be regarded as a persister-like
state and distinguished from the dormancy of naturally forming
persister cells. Other methods may also be used to generate high
frequencies of persister cells (e.g., overexpression of a toxin from
an inducible plasmid); for example, persistence has been induced
in exponential cell cultures through overexpression ofmqsR (21),
tisB (24), and relE (44) at the same order ofmagnitude achieved in
this study. However, the method developed in this study can be
applied towild-type cultures in nonsupplementedmedia and pro-
vides another viable method to study persisters.
Persister cell formation was first shown to be a stochastic pro-
cess (25), thought to result from fluctuations in gene expression
and protein levels within individual cells of an isogenic population
(45). Recent studies have suggested that persistence can also arise
as a result of environmental factors, including the presence of
ciprofloxacin (24), a bactericidal antibiotic, or indole (46), an in-
tercellular signaling molecule. Many antibiotic compounds are
naturally occurring in the environment, are produced by various
microorganisms, and are used to provide a competitive advantage
against neighboring species (47). The significant increase in per-
sistence we observe, after pretreatment with rifampin, tetracy-
cline, and CCCP, clearly shows several ways in which bacterial
persistence is induced via environmental pressure, rather than
solely via a stochastic event. Hence, it is apparent that while per-
sistence can result from stochastic fluctuations, it is also directly
affected by the presence of numerous extracellularmolecules. The
response of persister cell formation, when faced with the presence
of these natural inhibitory compounds, likely serves as an evolu-
tionarily developed mechanism for bacteria to subsist despite
chemical pressure from competing organisms.
ACKNOWLEDGMENTS
This work was supported by the NIH (grant R01 GM089999).
T.K.W. is the Biotechnology Endowed Professor at the Pennsylvania
State University.
REFERENCES
1. Bigger JW. 1944. Treatment of staphylococcal infections with penicillin
by intermittent sterilisation. Lancet 244:497–500.
2. Wiuff C, Zappala RM, Regoes RR, Garner KN, Baquero F, Levin BR.
2005. Phenotypic tolerance: antibiotic enrichment of noninherited resis-
tance in bacterial populations. Antimicrob. Agents Chemother. 49:1483–
1494.
3. Lewis K. 2007. Persister cells, dormancy, and infectious disease. Nat. Rev.
Microbiol. 5:48–56.
4. Lewis K. 2008. Multidrug tolerance of biofilms and persister cells. Curr.
Top. Microbiol. Immunol. 322:107–131.
5. Hall-Stoodley L, Costerton JW, Stoodley P. 2004. Bacterial biofilms:
from the natural environment to infectious diseases. Nat. Rev. Microbiol.
2:95–108.
6. Wolcott R, Dowd S. 2011. The role of biofilms: are we hitting the right
target? Plast. Reconstr. Surg. 127:28S–35S.
7. Jayaraman R. 2008. Bacterial persistence: some new insights into an old
phenomenon. J. Biosci. 33:795–805.
8. Spoering AL, Lewis K. 2001. Biofilms and planktonic cells of Pseudomo-
nas aeruginosa have similar resistance to killing by antimicrobials. J. Bac-
teriol. 183:6746–6751.
9. Lewis K. 2000. Programmed death in bacteria. Microbiol. Mol. Biol. Rev.
64:503–514.
10. Tan Q, Awano N, Inouye M. 2011. YeeV is an Escherichia coli toxin that
inhibits cell division by targeting the cytoskeleton proteins, FtsZ and
MreB. Mol. Microbiol. 79:109–118.
11. Wang X, Wood TK. 2011. Toxin-antitoxin systems influence biofilm and
persister cell formation and the general stress response. Appl. Environ.
Microbiol. 77:5577–5583.
12. Lewis K. 2010. Persister cells. Annu. Rev. Microbiol. 64:357–372.
13. Ren D, Bedzyk LA, Thomas SM, Ye RW, Wood TK. 2004. Gene
expression in Escherichia coli biofilms. Appl. Microbiol. Biotechnol. 64:
515–524.
14. González Barrios AF, Zuo R, Hashimoto Y, Yang L, Bentley WE, Wood
TK. 2006. Autoinducer 2 controls biofilm formation in Escherichia coli
Kwan et al.
1472 aac.asm.org Antimicrobial Agents and Chemotherapy
 o
n
 Septem
ber 11, 2018 by guest
http://aac.asm
.org/
D
ow
nloaded from
 
through a novel motility quorum-sensing regulator (MqsR, B3022). J.
Bacteriol. 188:305–316.
15. Wang X, Kim Y, Hong SH, Ma Q, Brown BL, Pu M, Tarone AM,
Benedik MJ, Peti W, Page R, Wood TK. 2011. Antitoxin MqsA helps
mediate the bacterial general stress response. Nat. Chem. Biol. 7:359–366.
16. Wang X, Lord DM, Cheng H-Y, Osbourne DO, Hong SH, Sanchez-
Torres V, Quiroga C, Zheng K, Herrmann T, Peti W, Benedik MJ, Page
R,WoodTK. 2012. A new type V toxin-antitoxin systemwheremRNA for
toxin GhoT is cleaved by antitoxin GhoS. Nat. Chem. Biol. 8:855–861.
17. Brown BL, Wood TK, Peti W, Page R. 2011. Structure of the Escherichia
coli antitoxin MqsA (YgiT/b3021) bound to its gene promoter reveals
extensive domain rearrangements and the specificity of transcriptional
regulation. J. Biol. Chem. 286:2285–2296.
18. Brown BL, Grigoriu S, Kim Y, Arruda JM, Davenport A, Wood TK, Peti
W, Page R. 2009. Three dimensional structure of the MqsR:MqsA com-
plex: a novel TA pair comprised of a toxin homologous to RelE and an
antitoxin with unique properties. PLoS Pathog. 5:e1000706. doi:10.1371
/journal.ppat.1000706.
19. Kim Y, Wang X, Zhang X-S, Grigoriu S, Page R, Peti W, Wood TK.
2010. Escherichia coli toxin/antitoxin pair MqsR/MqsA regulate toxin
CspD. Environ. Microbiol. 12:1105–1121.
20. Shah D, Zhang Z, Khodursky AB, Kaldalu N, Kurg K, Lewis K. 2006.
Persisters: a distinct physiological state of E. coli. BMCMicrobiol. 6:53.
21. Kim Y, Wood TK. 2010. Toxins Hha and CspD and small RNA regulator
Hfq are involved in persister cell formation through MqsR in Escherichia
coli. Biochem. Biophys. Res. Commun. 391:209–213.
22. Hong SH, Wang X, O’Connor HF, Benedik MJ, Wood TK. 2012.
Bacterial persistence increases as environmental fitness decreases.Microb.
Biotechnol. 5:509–522.
23. Yamaguchi Y, Park J-H, Inouye M. 2009. MqsR, a crucial regulator for
quorum sensing and biofilm formation, is a GCU-specific mRNA inter-
ferase in Escherichia coli. J. Biol. Chem. 284:28746–28753.
24. Dörr T, Vulic´ M, Lewis K. 2010. Ciprofloxacin causes persister formation
by inducing the TisB toxin in Escherichia coli. PLoS Biol. 8:e1000317. doi:
10.1371/journal.pbio.1000317.
25. Balaban NQ, Merrin J, Chait R, Kowalik L, Leibler S. 2004. Bacterial
persistence as a phenotypic switch. Science 305:1622–1625.
26. Allison KR, Brynildsen MP, Collins JJ. 2011. Heterogeneous bacterial
persisters and engineering approaches to eliminate them. Curr. Opin.Mi-
crobiol. 14:1–6.
27. Dörr T, Lewis K, Vulic´ M. 2009. SOS response induces persistence to
fluoroquinolones in Escherichia coli. PLoSGenet. 5:e1000760. doi:10.1371
/journal.pgen.1000760.
28. Wehrli W, Knüsel F, Schmid K, Staehelin M. 1968. Interaction of
rifamycin with bacterial RNA polymerase. Proc. Natl. Acad. Sci. U. S. A.
61:667–673.
29. Chopra I, Roberts M. 2001. Tetracycline antibiotics: mode of action,
applications, molecular biology, and epidemiology of bacterial resistance.
Microbiol. Mol. Biol. Rev. 65:232–260.
30. Cavari BZ, Avi-Dor Y, Grossowicz N. 1967. Effect of carbonyl cyanide
m-chlorophenylhydrazone on respiration and respiration-dependent
phosphorylation in Escherichia coli. Biochem. J. 103:601–608.
31. Sambrook J, Fritsch EF, Maniatis T. 1989. Molecular cloning: a labora-
tory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring
Harbor, NY.
32. Donegan K, Matyac C, Seidler R, Porteous A. 1991. Evaluation of
methods for sampling, recovery, and enumeration of bacteria applied to
the phylloplane. Appl. Environ. Microbiol. 57:51–56.
33. Sanders CC. 1988. Ciprofloxacin: in vitro activity, mechanism of action,
and resistance. Rev. Infect. Dis. 10:516–527.
34. Fisher JF, Meroueh SO, Mobashery S. 2005. Bacterial resistance to
-lactam antibiotics: compelling opportunism, compelling opportunity.
Chem. Rev. 105:395–424.
35. Tuomanen E, Cozens R, Tosch W, Zak O, Tomasz A. 1986. The rate of
killing of Escherichia coli by -lactam antibiotics is strictly proportional to
the rate of bacterial growth. J. Gen. Microbiol. 132:1297–1304.
36. Wehrli W. 1983. Rifampin: mechanisms of action and resistance. Rev.
Infect. Dis. 5:S407–S411.
37. Calvori C, Frontali L, Leoni L, Tecce G. 1965. Effect of rifamycin on
protein synthesis. Nature 207:417–418.
38. Stubbings W, Bostock J, Ingham E, Chopra I. 2006. Mechanisms of the
post-antibiotic effects induced by rifampicin and gentamicin in Esche-
richia coli. J. Antimicrob. Chemother. 58:444–448.
39. Keren I, Kaldalu N, Spoering A, Wang Y, Lewis K. 2004. Persister cells
and tolerance to antimicrobials. FEMS Microbiol. Lett. 230:13–18.
40. Athamna A, Athamna M, Medlej B, Bast DJ, Rubinstein E. 2004. In vitro
post-antibiotic effect of fluoroquinolones, macrolides,-lactams, tetracy-
clines, vancomycin, clindamycin, linezolid, chloramphenicol, quinupris-
tin/dalfopristin and rifampicin on Bacillus anthracis. J. Antimicrob. Che-
mother. 53:609–615.
41. Gal K. 1965. Combined antibiotic therapy. Can. Med. Assoc. J. 93:
844–847.
42. Forrest GN, Tamura K. 2010. Rifampin combination therapy for non-
mycobacterial infections. Clin. Microbiol. Rev. 23:14–34.
43. Roberts MC. 2003. Tetracycline therapy: update. Clin. Infect. Dis. 36:
462–467.
44. Maisonneuve E, Shakespeare LJ, Jørgensen MG, Gerdes K. 2011. Bac-
terial persistence by RNA endonucleases. Proc. Natl. Acad. Sci. U. S. A.
108:13206–13211.
45. Kint CI, Verstraeten N, Fauvart M, Michiels J. 2012. New-found fun-
damentals of bacterial persistence. Trends Microbiol. 20:577–585.
46. Vega NM, Allison KR, Khalil AS, Collins JJ. 2012. Signaling-mediated
bacterial persister formation. Nat. Chem. Biol. 8:431–433.
47. Fajardo A, Martínez JL. 2008. Antibiotics as signals that trigger specific
bacterial responses. Curr. Opin. Microbiol. 11:161–167.
48. Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, Baba M, Datsenko
KA, Tomita M, Wanner BL, Mori H. 2006. Construction of Escherichia
coli K-12 in-frame, single-gene knockout mutants: the Keio collection.
Mol. Syst. Biol. 2:2006.0008. doi:10.1038/msb4100050.
Arrested Protein Synthesis Increases Persistence
March 2013 Volume 57 Number 3 aac.asm.org 1473
 o
n
 Septem
ber 11, 2018 by guest
http://aac.asm
.org/
D
ow
nloaded from
 
